2026-05-10
Isomorphic Labs, an Alphabet unit focused on AI-driven drug development, is reportedly in discussions for a new funding round. The investment is expected to exceed billion, with Thrive Capital anticipated to lead.
Source: SiliconANGLE
Reported by VERA Newswire.